A detailed history of Citigroup Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 70,295 shares of IONS stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,295
Previous 76,618 8.25%
Holding current value
$2.49 Million
Previous $3.65 Million 22.87%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$40.06 - $51.86 $253,299 - $327,910
-6,323 Reduced 8.25%
70,295 $2.82 Million
Q2 2024

Aug 12, 2024

SELL
$36.45 - $47.7 $5.33 Million - $6.98 Million
-146,325 Reduced 65.63%
76,618 $3.65 Million
Q1 2024

May 10, 2024

BUY
$42.03 - $53.55 $5.16 Million - $6.57 Million
122,698 Added 122.4%
222,943 $9.66 Million
Q4 2023

Feb 09, 2024

SELL
$43.39 - $51.63 $3.88 Million - $4.61 Million
-89,375 Reduced 47.13%
100,245 $5.07 Million
Q3 2023

Nov 09, 2023

BUY
$38.5 - $47.13 $4.15 Million - $5.08 Million
107,873 Added 131.96%
189,620 $8.6 Million
Q2 2023

Aug 10, 2023

SELL
$34.73 - $43.33 $3.59 Million - $4.47 Million
-103,226 Reduced 55.81%
81,747 $3.35 Million
Q1 2023

May 11, 2023

BUY
$33.58 - $41.2 $1.88 Million - $2.3 Million
55,844 Added 43.25%
184,973 $6.61 Million
Q4 2022

Feb 09, 2023

SELL
$37.12 - $46.52 $1.78 Million - $2.23 Million
-47,863 Reduced 27.04%
129,129 $4.88 Million
Q3 2022

Nov 10, 2022

BUY
$36.54 - $48.66 $1.02 Million - $1.36 Million
27,861 Added 18.68%
176,992 $7.83 Million
Q2 2022

Aug 10, 2022

BUY
$31.71 - $43.0 $2.15 Million - $2.92 Million
67,795 Added 83.35%
149,131 $5.52 Million
Q1 2022

May 12, 2022

SELL
$29.88 - $37.04 $3.13 Million - $3.88 Million
-104,711 Reduced 56.28%
81,336 $3.01 Million
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $1.66 Million - $2.28 Million
64,983 Added 53.68%
186,047 $5.66 Million
Q3 2021

Nov 10, 2021

BUY
$33.54 - $40.55 $4.06 Million - $4.91 Million
121,064 New
121,064 $4.06 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.